Site Search
Search Results
Advocates to Gov. Ferguson: Cancer Can’t Be Acceptable Outcome of State Budget-cutting Process
... Wash. -– American Cancer Society Cancer Action Network advocates call on Washington Gov. Bob Ferguson to refuse to allow the long-term health of Washington residents to become collateral damage to the state’s current budget crisis. The state’s cancer prevention programs are one of the ... constituents as possible have access to screening for three of the state’s most prevalent forms of cancer. The following statement can be attributed to Audrey Miller Garcia, Government Relations Director for ACS CAN Washington: “The potential for budget cuts to do serious ... and cessation or the Breast, Cervical, and Colon Screening Program will damage Washington families well beyond their bank accounts. The cost will be the health of our children and lives of our loved ones. This is not political posturing. It’s based in data and is not a possibility ...
Cancer Patients and Survivors Urge Legislators to Make Biomarker Access a Priority, Eliminate Flavored Tobacco Sales
... Washington gathered at the Capitol building Monday to ask legislators to support House Bill 1062, which would expand insurance coverage of biomarker testing, making sure as many state residents as possible have access to this technology. Biomarker testing is about identifying the most effective treatment for patients with cancer and other serious illnesses. It can open the door to precision treatments that can improve outcomes and quality of life for patients with many diseases and conditions. Similar legislation has passed in 20 states including California, Texas, Georgia and ...
Advocates Call on Washington Lawmakers to Prioritize Expanding Access to Biomarker Testing
... biomarker testing. Biomarker testing is about identifying the most effective treatment for patients with cancer and other serious illnesses. It can open the door to precision treatments that can improve outcomes and quality of life for patients with many diseases and conditions. Similar legislation has passed in 20 states including California, Texas, Georgia and New ... costs and avoiding potentially life-altering side effects. It’s notable that biomarker testing is increasingly important to the treatment of conditions outside of the cancer space, like arthritis and other autoimmune conditions, organ and tissue transplant, and rare diseases. Research ...